Literature DB >> 20035371

Human dermal fibroblast proliferation activity of usimine-C from Antarctic lichen Ramalina terebrata.

Sung Gu Lee1, Hye Yeon Koh, Hyuncheol Oh, Se Jong Han, Il-Chan Kim, Hong Kum Lee, Joung Han Yim.   

Abstract

Type I collagen is the major structural protein in dermis and its presence is used to monitor skin cell proliferation and aging. Recently, novel usimine compounds have been found in the Antarctic lichen Ramalina terebrata. In the present study, usimine-C induced cell proliferation of human dermal fibroblast, CCD-986SK, up to 1.6-fold after treating with 90 microg/ml for 48 h. Type I procollagen synthesis was significantly increased 1.3-fold, 3-fold, and 5-fold after treating with 0.14, 0.72, and 3.6 microg usimine-C/ml for 24 h, respectively, whereas no significant increase in type I procollagen was observed after treating with usimine-A or -B. Usimines are usnic acid derivatives. Considering that the difference among the derivatives is a side chain, the proliferation activity may be related to this side chain, triggering an internal signal for type I procollagen expression. Further studies still remain to clarify the signaling pathways for the type I procollagen induction, which is activated by usimine-C.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035371     DOI: 10.1007/s10529-009-0191-2

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  Stereocalpin B, a New Cyclic Depsipeptide from the Antarctic Lichen Ramalina terebrata.

Authors:  Seulah Lee; Se Yun Jeong; Dieu Linh Nguyen; Jae Eun So; Ki Hyun Kim; Ji Hee Kim; Se Jong Han; Sung-Suk Suh; Jun Hyuck Lee; Ui Joung Youn
Journal:  Metabolites       Date:  2022-02-03

2.  Secondary Metabolites in Ramalina terebrata Detected by UHPLC/ESI/MS/MS and Identification of Parietin as Tau Protein Inhibitor.

Authors:  Alberto Cornejo; Francisco Salgado; Julio Caballero; Reinaldo Vargas; Mario Simirgiotis; Carlos Areche
Journal:  Int J Mol Sci       Date:  2016-08-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.